SCHEMBL4930360

SCHEMBL4930360

Cn1c(CCC(C(=O)OCc2ccccc2)N(CC2CCCCC2)C(=O)OC(C)(C)C)nc2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.41
ALDH1A1 P00352 2/20 0.40
MAPT P10636 1/20 0.39
ALOX5 P09917 1/20 0.38
LMNA P02545 2/20 0.37
KMT2A Q03164 1/20 0.37
CCR5 P51681 2/20 0.37
HTR2C P28335 2/20 0.36
SLC6A4 P31645 2/20 0.36
RECQL P46063 1/20 0.36
HCRTR1 O43613 1/20 0.36
HCRTR2 O43614 1/20 0.36
REN P00797 1/20 0.35
TSHR P16473 1/20 0.35
PDE10A Q9Y233 1/20 0.35
RXRA P19793 1/20 0.34
RXRB P28702 1/20 0.34
RXRG P48443 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4930352 1.00 HDAC6 (0.41) HDAC6ALDH1A1MAPTALOX5LMNA
SCHEMBL4931869 0.91 CCR5 (0.39) MAPTLMNAKMT2ACCR5POLB
SCHEMBL4931860 0.91 CCR5 (0.39) MAPTLMNAKMT2ACCR5POLB
SCHEMBL4933280 0.90 HDAC6 (0.45) HDAC6ALDH1A1MAPTALOX5LMNA
SCHEMBL4933285 0.90 HDAC6 (0.45) HDAC6ALDH1A1MAPTALOX5LMNA
SCHEMBL4935053 0.89 ALDH1A1 (0.40) HDAC6ALDH1A1MAPTALOX5LMNA
SCHEMBL4935045 0.89 ALDH1A1 (0.40) HDAC6ALDH1A1MAPTALOX5LMNA
SCHEMBL4926824 0.85 HDAC6 (0.45) HDAC6ALDH1A1MAPTLMNACCR5
SCHEMBL4926816 0.85 HDAC6 (0.45) HDAC6ALDH1A1MAPTLMNACCR5
SCHEMBL4930392 0.83 HDAC6 (0.42) HDAC6ALDH1A1MAPTRECQLTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative KUREHA CORPORATION (JP) 2008-06-05 US disclosed
EP-1707560-A1 HYDROXAMIC ACID DERIVATIVE AND AGE GENERATION INHIBITOR CONTAINING THE DERIVATIVE Kureha Corporation (JP) 2006-10-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative HDAC5, HDAC1, HDAC9 HDAC6 10/4885ALDH1A1 1829/4885MAPT 2275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.